Home › Funds › Marshall Wace › DNLI
Marshall Wace position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)549.83K sh
Reported value held$14.14M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 531.36K | $26.81M | New |
| Q4 2021 | 383.94K | $17.12M | Reduce |
| Q1 2022 | 152.85K | $4.92M | Reduce |
| Q2 2022 | 817.65K | $24.06M | Add |
| Q3 2022 | 675.87K | $20.74M | Reduce |
| Q4 2022 | 960.64K | $26.72M | Add |
| Q1 2023 | 350.54K | $8.08M | Reduce |
| Q4 2023 | 1.67M | $35.78M | New |
| Q1 2024 | 2.15M | $44.04M | Add |
| Q2 2024 | 2.42M | $56.17M | Add |
| Q3 2024 | 1.97M | $57.30M | Reduce |
| Q4 2024 | 1.79M | $36.45M | Reduce |
| Q1 2025 | 2.19M | $29.76M | Add |
| Q2 2025 | 1.41M | $19.66M | Reduce |
| Q3 2025 | 787.03K | $11.43M | Reduce |
| Q4 2025 | 763.89K | $12.61M | Reduce |
| Q1 2026 | 991.27K | $19.03M | Add |
| Q2 2026 | 549.83K | $14.14M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026